Please Login to read the full article.
PRA to work with Opexa on MS trials
29 February 2012
|
Joanne Payne
Scrip Clinical Research
Not
a subscriber ? Request a FREE Trial
Subscribe to GCPj
NEWS
Scrip Clinical Research News
Court slams Indian govt over tardy response to 'illegal' trials litigation
ClinTec opens in Malawi
ICON expands hospital-based presence for translational medicine
Clinigen signs clinical trial distribution agreement with Accord for injectable cancer drugs
Other News
Merck Serono takes option on resurrected T cell therapy for MS
Nektar raises new $125m debt to clean out old debt and focus on asset progress
US FDA underlines moves to improve reg system and encourage innovation, more open dialogue
IPO or ATM? Quintiles insiders take cash, Receptos enters market
FEATURES & ANALYSIS
Scrip Clinical Research Features & Analysis
Real-world and late-phase studies in "pharmerging" markets: challenges and best practices in implementation
EndPoint - Dr Frederick Young, INC Research
New approaches bring hope for peripheral artery disease
Standard and novel strategies for early phase oncology clinical research
Other Features & Analysis
Mapping the US approvals landscape in 2013
GlaxoSmithKline: three billion lessons learned
Obtaining scientific advice from drug regulators - the good, the bad and the ugly
Is a pan-European approach the way forward for health technology assessment?
EVENTS
Expecting data for this section.
